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Cell cultures of NTera-2 cells incubated with bleomycin and liposomes as biomimetic models of cell membranes were used for 
examining novel aspects of drug-metal induced reactivity with unsaturated lipids under oxidative conditions. In cell culture, 
bleomycin was found for the first time to cause the formation of trans fatty acids. The chemical basis of this transformation was 
ascertained by liposome experiments, using bleomycin-iron complexes in the presence of thiol as reducing agent, that by 10 
incubation at 37 °C gave rise to the thiyl radical-catalysed double bond isomerisation of membrane phospholipids. The effect of 
oxygen and reagent concentrations on the reaction outcome was studied. An interesting scenario of free radical reactivity is 
proposed, which can be relevant for the role of membrane lipids in antitumoral treatments and drug carrier interaction. 
Introduction 
The glycopeptide antibiotic bleomycin (BLM), used 15 
in chemotherapy against neck, head and testicular 
cancers as well as Hodgkin lymphoma, has a long-
studied mechanism of action, based on the formation 
of a complex with metals, such as iron, which under 
aerobic conditions generates reactive oxygen species 20 
(ROS) thus causing DNA damage.1-3 Figure 1 
summarizes the BLM behaviour in the presence of 
Fe(II) and O2, to produce activated forms of the drug 
and hydroxyl radicals.2,4,5 In the presence of 
polyunsaturated fatty acids (PUFA) their 25 
consumption via peroxidation is known to occur.1,3,6  
 
 
 
 30 
 
 
 
 
 35 
 
 
 
 
Fig. 1 Reactivity pathways of the BLM-iron 40 
complexes with unsaturated fatty acids. In the 
presence of oxygen, drug activated forms and 
hydroxyl radicals can be formed and produce PUFA 
consumption; in the presence of thiols, the reduction 
of Fe(III) to Fe(II) occurs with formation of thiyl 45 
radicals, which can catalyse the cis-trans double bond 
isomerisation of unsaturated fatty acid residues (in 
blue colour). 
 
So far, the molecular basis of the drug activity are 50 
focused on DNA damage especially at mitochondria 
level, determining pulmonary side toxicity7 and 
motivating interest in possible antioxidant 
combinations.8 On the other hand, redox-based 
antioxidants, such as thiols, are known to increase the 55 
drug effectiveness, their effect being explained by the 
recycling of BLM-Fe(III) to BLM-Fe(II) (see Figure 
1).9 During the reductive process the production of 
thiyl radicals can occur, which are known to react 
with double bonds and catalyse the isomerisation of 60 
the natural cis unsaturated fatty acids to the 
corresponding geometrical trans isomers (see Figure 
1, blue colour). This reaction can involve 
monounsaturated fatty acids (MUFA) and PUFA and 
is particularly relevant in biological systems, when 65 
affecting membrane lipids.10 It is not known whether 
lipid isomerisation is connected with the effects of 
metals and generation of reactive oxygen species that 
cause cell death.11 The perturbation produced by the 
unnatural trans geometry to membrane properties12,13 70 
is a dramatic event for the eukaryotic cell survival. Its 
potential as a strategy for antitumoral activity has not 
yet been evaluated. 
It is worth noting that drug-metal complex chemistry 
provides efficient catalysis for C-H activation and 75 
C=C oxidation,14 whereas the reactivity towards 
double bonds and the isomerization represent new 
aspects to be developed. 
After our preliminary experiments evidencing the 
trans fatty acid formation by bleomycin treatment,15 80 
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we thought to apply an original chemical biology 
model for the investigation of the drug-induced 
chemical reactivity by combining the data of the cell 
culture experiments with biomimetic chemistry in 
liposome vesicles. Our aim was to furnish a 5 
comprehensive scenario of the drug behaviour with 
membrane fatty acids. Here we report the fatty acids 
of human testicular cancer cell membranes (NTera-2) 
incubated with bleomycin under standard conditions, 
paralleled with those forming liposomes under 10 
similar incubation conditions. Using liposome models 
more detailed chemical information could be 
gathered varying the reaction conditions, for the 
oxygen, drug and thiol concentrations. We anticipate 
that bleomycin-induced thiyl radical reactivity was 15 
discovered causing cis-trans lipid isomerization, and 
the chemical behaviour of membrane lipids in 
liposomes helped to understand also the outcome in 
the cellular model. 
Results and Discussion 20 
 
Cell cultures  
The fatty acid composition of human testicular cancer 
cell membranes (NTera-2) was examined before and 
after 24 h incubation with bleomycin. To our 25 
knowledge, there is only one study on the fatty acid 
composition of this cell type,16 and the fatty acid 
profiles of testicular cancer cells in response to 
antitumoral drugs are unknown. Bleomycin was used 
at the IC50 dose of 400 µg/mL. Details of the 30 
incubation and fatty acid composition of cell 
membranes are given in the Materials and Methods 
section as well as in Supplementary Information. 
Briefly, after incubation cells were thoroughly 
washed in order to obtain samples of 4×106 cells 35 
suspended in phosphate buffer, followed by 
membrane phospholipid isolation, transformation of 
the fatty acid residues in fatty acid methyl esters 
(FAME) and gas chromatographic (GC) analysis, in 
order to examine the fatty acid moieties detached 40 
from the phospholipids by known methods.17-19 
 Table 1 shows the fatty acid residues found in 
treated versus control cells. Results are reported as 
percentage of fatty acids over the total fatty acid 
content and as means ± sd with statistical significance 45 
of n repetitions. In cultured cells a considerable 
percentage of trans MUFA isomers (trans-16:1 and 
trans-18:1), identified by appropriate libraries,20,21 
was found, equivalent to a 24% isomerisation of the 
total MUFA content. A significant diminution of the 50 
corresponding cis-MUFA (cis-16:1 and cis-18:1) was 
correspondently observed. For the omega-6 PUFA, 
the diminution of cis isomers (18:2 and 20:4 with 
p<0.05) was also accompanied by the trans PUFA 
isomers formation, identified as mono-trans linoleic 55 
acid isomers,18 (see Supplementary Information, 
Figure 3s) reaching ca. a 20% isomerisation of the 
18:2 content, together with mono-trans arachidonic 
acid isomers,17 reaching ca. 2% of the total 20:4 
content.  60 
The formation of trans isomers was not known 
previously in the mechanism of action of antitumoral 
drugs, and it is worth underlining that membrane lipid 
reactivity with change of naturally occurring cis 
geometry is a new aspect of the free radical-based 65 
antitumoral drug effect. Other details connected with 
the fatty acid transformations are reported in 
Supplementary Information, which showed also a 
profound membrane lipid remodelling with change of 
the membrane fatty acid asset. 70 
This behaviour inspired a biomimetic chemistry study 
in membrane models, constituted of liposomes 
containing MUFA and PUFA residues, using 
bleomycin as complex with iron and a reducing agent 
such as thiols, to create the recycling of the redox 75 
state of the complexes, which is at the basis of the 
activity as depicted in Figure 1.  
 
Set-up of the liposome experiments 
Unilamellar liposomes (Large Unilamellar Vesicle by 80 
extrusion technique, LUVET) were designed since 
they represent the best biomimetic model for 
investigating cell membrane phospholipid behaviour. 
Experiments were carried out with liposomes of two 
different lipid compositions at 1 mM concentration: 85 
the first one made of the synthetic phospholipid, 1-
palmitoyl-2-oleoyl phosphatidyl choline (POPC), 
whereas the second one made of natural 
phospholipids such as soybean lecithin, containing 
different percentages of saturated, mono- and 90 
polyunsaturated (MUFA and PUFA) fatty acids (see 
Supplementary Information). The reactivity of 
unsaturated fatty acids, studied by us in other 
biomimetic models in the presence of thiols,17,18,22 can 
involve MUFA and PUFA residues: the MUFA 95 
moiety of oleic acid (9cis-18:1) is not so prone to 
oxidation as PUFAs are, whereas it can be the target 
of the thiyl radical catalysed-isomerisation, being 
transformed into elaidic acid (9trans-18:1). On the 
other hand PUFA residues of soybean lecithin 100 
liposomes can be partitioned between oxidative and 
isomerisation pathways. In particular, linoleic acid 
(9cis,12cis-18:2), which is the most representative 
PUFA in the lecithin (17.5% of the total fatty acid 
composition), can give three geometrical trans 105 
isomers: 9trans,12cis-18:2, 9cis,12trans-18:2, 
9trans,12trans-18:2, which can be clearly separated 
by GC analysis (see Figure 3s in Supplementary 
Information). We were aware of lipid oxidation in the 
mechanism of bleomycin, as depicted in Figure 1, 110 
and we measured it by fatty acid consumption after 
the reactions, using the GC calibration curves vs. the 
saturated fatty acid residue of palmitic acid 
(hexadecanoic acid, 16:0). This fatty acid is present 
in both POPC and soybean liposomes and can act as 115 
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internal standard, being unreactive under free radical 
conditions. MUFA and PUFA yields were calculated 
from their peak areas in the GC analysis, which is the 
gold standard for fatty acid quantification. Control 
experiments included also the liposome reaction in 5 
the presence of the metal-thiol complex without 
bleomycin, in order to better estimate the drug 
contribution to lipid reactivity. 
 
Table 1 Membrane fatty acid composition of NTera-10 
2 cells (reported as fatty acid methyl esters (FAME, 
% rel. ± sd) incubated for 24 h with bleomycin (at 
IC50 = 400 µg/mL). 
 
 15 
The values are reported as relative percentage (% 
rel) of the total fatty acid peak areas detected in the 
GC analysis (recognition > 98% of the peaks). The 
values are given as mean ± sd. n is the number of the 
tests repeated. Statistical comparisons were 20 
conducted using the SPSS software, version 13.0 
(Chicago, IL), using t-test for group comparisons. 
Statistical significance was based on 95% confidence 
limits (p≤0.05). Comparison of the non-parametric 
data among the groups was performed using Mann-25 
Whitney U test.  
a
 FAME (fatty acid methyl ester) were determined 
performing membrane phospholipid extraction, 
derivatization, and GC analysis. b The identification 
of the peaks was performed using authentic samples. c 30 
The sum of the geometrical isomers is considered, 
i.e., 6-trans and 9-trans for 16:1,21 9cis,12trans-18:2 
and 9trans,12cis-18:2 for 18:2,18 the four mono-trans 
isomers of 20:4.17 * Values significantly different 
from the control, p<0.05. *** Values significantly 35 
different from the control, p<0.001. 
 
In the liposome model design 2-mercaptoethanol was 
chosen as the thiol for its amphiphilic character, in 
order to diffuse freely in the heterogeneous 40 
environment of liposome suspension and interact 
with the membrane compartment. Other thiols, such 
as cysteine, glutathione and N-acetylcysteine, were 
used in comparative experiments under aerobic 
conditions to estimate the effect of different partition 45 
coefficients (see below).  
 The bleomycin-iron complex was prepared as 
described in the literature,23 directly in the liposome 
suspension, briefly by adding bleomycin sulphate, 
ferrous ammonium sulphate (10 µM each) and thiol 50 
at the desired concentration (10 and 100 µM) to the 
vesicle aqueous suspension (1 mM), keeping the test 
tubes under controlled aerobic conditions (mixture 
with nitrogen at 5, 10 and 20% oxygen) or under 
nitrogen (0% oxygen). The concentration of 55 
bleomycin-iron complex was chosen as the one 
reported in lipid peroxidation experiments of 
chemical and biological models.3,9 The steps of 
formation of the iron-drug complex with oxygen, and 
the role of thiol (RSH) with the formation of the 60 
Fe(III)-bleomycin-thiol complex occur as depicted in  
Figure 1.1-5 UV-vis spectra were carried out to 
ascertain the formation of the absorbance band of the 
BLM-Fe-SR complex at 580 nm, as described in the 
literature (see Supplementary Information).9 65 
 
MUFA-containing vesicles 
The results for the reaction of POPC vesicles are 
summarized in the graph of Figure 2 (green and violet 
bars). The trans isomer formation was detected after 70 
24 h incubation with 10 µM bleomycin-iron(II) salt 
and 10 µM 2-ME at 37 °C, under the three different 
oxygen concentrations used (20%, 10% and 5%). The 
BLM-iron-thiol triad caused lipid isomerisation, 
inversely correlated with the oxygen presence. For 75 
example, in POPC liposomes oleic acid isomerisation 
went from ca. 27% trans isomer formation with 5% 
oxygen to ca. four-fold less in the presence of 20% 
oxygen. The same experiments were run without 
bleomycin, in order to define the contribution of drug 80 
reactivity to the lipid isomerisation. When only the 
iron-thiol complex is present, a decisive decrease in 
the isomerisation efficiency occurred, which remains 
inversely correlated with oxygen concentration. In 
this case trans isomers were formed in POPC in the 85 
range of 5%-1.2% going from 5% to 20% oxygen 
(Figure 2). Comparing the presence and the absence 
of the drug under the same oxygen conditions, a 5.5 
to 7-folds decrease of isomerisation can be observed. 
Therefore, bleomycin gives a substantial contribution 90 
to the generation of thiyl radical species and trans 
fatty acid formation under aerobic conditions. 
It is worth noting that the isomerisation of double 
 
FAME a,b Control (n=8) Bleomycin (n=6) 
14:0 2.4 ± 0.4 1.3 ± 0.1* 
16:0 28.0 ± 0.7 27.1 ± 1.7 
trans-16:1c 0.1 ± 0.04 0.3 ± 0.2*** 
6cis-16:1 2.0 ± 0.5 0.8 ± 0.04* 
9cis-16:1 1.4 ± 0.4 0.5 ± 0.04* 
18:0 35.8 ± 5.9 50.4 ± 0.6* 
9trans-18:1 0.1 ± 0.03 2.2 ± 1.1*** 
9cis-18:1 15.8 ± 2.5 6.8 ± 0.6* 
11cis-18:1 4.3 ± 0.7 2.1 ± 0.1* 
mono-trans 18:2c 0.3 ± 0.3 0.1 ± 0.0 
18:2 ω6 0.7 ± 0.2 0.4 ± 0.05* 
20:0 0.8 ± 0.3 1.3 ± 0.02* 
20:1 0.9 ± 0.2 2.4 ± 1.2 
20:3 ω6 0.4 ± 0.1 1.5 ± 0.9* 
mono-trans 20:4c 0.04 ± 0.03 0.1 ± 0.03 
20:4 ω6 6.8 ± 2.2 3.4 ± 0.1* 
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bonds requires catalytic thiyl radicals, so that 
appreciable quantities of trans isomers are formed 
also at very low radical concentration.10 For this 
reason trans lipids can be used as sensitive markers 
of thiyl radical generation in complex systems. Using 5 
the palmitic acid moiety of phospholipids as internal 
standard, it was also possible to ascertain that the 
molarity of the 18:1 substrate did not change from the 
initial one (1 mM), showing that no MUFA 
consumption occurs by oxidative process under our 10 
experimental conditions.  
   
 
 
 15 
 
 
 
 
 20 
 
 
 
 
 25 
 
 
Fig. 2 Trans 18:1 isomer formation (% rel., see Table 
1s in Supplementary Information) in POPC or 
lecithin vesicles treated with 10 µM Fe(II) and 10 µM 30 
2-mercaptoethanol in the presence or absence of 
BLM, under variable oxygen concentrations and 
reagents. The mean ± sd values were calculated from 
triplicates of the same experiment (see Table 1s in 
Supplementary Information).  35 
 
The effect of thiol concentration, which in living 
organisms can reach mM concentrations, was assayed 
by increasing 2-ME by ten-folds (100 µM), keeping 
the presence of BLM-Fe(II) at 10 µM concentration 40 
each (data not shown). Under this condition, trans 
isomer formation in POPC vesicles dropped (ca 3.7-
1.1% depending on the oxygen concentration). On the 
other hand, in the absence of bleomycin, the 
increased concentration of thiol (100 µM) in the 45 
presence of 10 µM Fe(II) in POPC vesicles produced 
a higher isomerisation percentage (ca. 7.6-4% trans 
isomer depending on oxygen concentration). 
Therefore, in MUFA-containing liposomes the 
isomerisation process under aerobic conditions was 50 
more effective with the drug and 10 µM thiol 
concentrations (see Figure 2), than with a higher thiol 
concentration, which is even insensitive to BLM. 
Obviously, in the absence of thiol no isomerisation 
was detected. The reasons of this behaviour and the 55 
connection of bleomycin reactivity with the variation 
of local co-reactant concentrations are matter of 
further work, also in view of an extrapolation to 
factors altering the drug activity in vivo.  
In POPC vesicles the efficiency of other thiol 60 
compounds was also tested (data not shown). 
Cysteine and glutathione, which are hydrophilic 
thiols, did not afford trans isomer. This can be easily 
explained on the basis of no thiol partition in 
membrane bilayer, as already reported.18 The less 65 
hydrophilic N-acetylcysteine (10 and 100 µM 
concentrations) gave a low but detectable trans 
isomer formation after 24 h of incubation (up to 3-4% 
trans 18:1, data not shown). These results are 
intriguing, when paralleled with the cell models 70 
showing an efficient formation of trans isomers in 
NTera-2 cells treated with bleomycin and without 
specific thiol addition. These results suggest further 
investigations toward the individuation of possible 
biological candidates for the generation of thiyl 75 
radicals by drug interaction in vivo.  
 
MUFA- and PUFA-containing liposomes 
Liposomes were also prepared with soybean lecithin 
and used for analogous experiments with bleomycin. 80 
In such MUFA and PUFA-containing liposomes the 
oleic and linoleic transformations to the 
corresponding geometrical isomers (9trans-18:1 and 
trans 18:2 isomers) were followed-up, estimating also 
the PUFA consumption by oxidative degradation (see 85 
Figure 3s in Supplementary Information). The BLM-
iron-thiol triad, each at 10 µM concentration, 
produced trans 18:1 isomer (for example, ca. 8.5% at 
5% oxygen; see Figure 2, red bars). In these 
experiments PUFA content strongly diminished after 90 
the first 2 h incubation (consumption >92%, not 
shown), thus isomerization of linoleic acid residues 
was not detectable. The PUFA oxidative pathway 
depicted in Figure 1 is clearly operative. Further 
experiments were carried out to evaluate the roles of 95 
bleomycin and oxygen in the reaction outcome. 
Under aerobic conditions and in the absence of 
bleomycin, PUFA consumption generated by metal 
and thiols was always high (>91%), whereas the 18:1 
isomerisation was less efficient (for example, ca. 4-100 
5% at 5% oxygen, see Figure 2, blue bars).  
The role of oxygen was exploited under anaerobic 
conditions (with nitrogen at 0% oxygen) in lecithin 
liposomes treated with different conditions of drug 
and thiol, and the results are reported in Table 2. 105 
After 24 h incubation with 10 µM drug-thiol-iron 
triad, the formation of trans MUFA and PUFA 
isomers (ca. 2.5% each) was observed, and was 
coupled with PUFA consumption of ca. 14%. The 
same experiment repeated without bleomycin, with 110 
thiol-metal complex, led to an even lower 
isomerisation (<1%) and no PUFA consumption. 
From these experiments it can be highlighted that 
bleomycin is the responsible of PUFA consumption 
also when oxygen is absent. The effect of higher thiol 115 
concentration was tested with 100 µM concentration 
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and Table 2 shows that under anaerobic conditions 
the PUFA reactivity is almost similarly partitioned 
between isomerisation and consumption, with 
comparable results in the presence and absence of the 
drug. Therefore, at higher thiol concentration the 5 
BLM effect for isomerisation can be considered 
negligible, whereas the system ensures that thiyl 
radical generation occurs for the consistent formation 
of trans 18:1 and 18:2 isomers.  
A more detailed study was carried out on the 10 
structure of the fatty acid isomers produced in the 
experiments reported in Table 2. It was gratifying to 
see that the three trans 18:2 isomers were formed in 
the liposomes at different percentages and in the 
order: 9trans,12cis > 9trans,12trans > 9cis,12trans. 15 
This shows that the isomerisation occurs as a 
regioselective process, which is expected as 
consequence of the supramolecular arrangement of 
fatty acids in the bilayer (see Supplementary 
Information, Figures 3s and 4s).17,18 20 
In anaerobic experiments the PUFA consumption 
(reaching 60% at higher thiol concentration), not 
attributable to oxidative processes, was also 
preliminary investigated examining the crude reaction 
mixture. The phospholipid extract was transformed 25 
into the corresponding FAME derivatives and 
analysed by GC/MS under appropriate conditions. 
The presence of thiol-linoleic acid adducts was 
ascertained by comparison with reference compounds 
(see Supplementary Information, Figure 5s).18  30 
These results indicate an intricate relationship 
between the drug and thiol compounds to be 
extrapolated to the variability of drug effectiveness 
under different nutritional and oxygen conditions, 
that can influence the response of cancer tissues. 35 
 
Table 2 Reactivity of 18:1 and 18:2 residues and 
PUFA consumption in lecithin liposomes under 
anaerobic conditions (nitrogen with 0% oxygen) 
incubated for 24 h at 37 °C with 10 µM Fe(II) salt, 40 
and in the presence/absence of bleomycin (BLM) and 
2-mercaptoetanol (2-ME). The mean ± sd values 
were calculated from triplicates of the same 
experiment. 
 45 
 
aEach trans isomer is reported as percentage 
relative to the sum of the corresponding cis and trans 
isomers found as peak of the GC analysis of the 
corresponding FAME. For the isomer recognition see 
Table 1. bThe PUFA consumption is calculated by 50 
using the linoleic acid GC peak areas (cis + trans 
isomers) before and after 24 h incubation calibrated 
vs. palmitic acid used as the internal standard (see 
Supplementary Information). *See Figure 4s in 
Supplementary Information for the GC analysis 55 
relative to the identification of each trans 18:2 
isomers. **See Figure 5s in Supplementary 
Information for the identification of thiol-linoleic 
acid adducts in the reaction mixture. 
 60 
Conclusions 
The general aim of our study was to get molecular 
insights of the drug-metal complexes acting via free 
radical production, examining a well known 
chemotherapeutic agent, such as bleomycin, and 65 
considering the novel aspect of membrane 
unsaturated lipid reactivity via double bond 
isomerization. Although bleomycin-iron complex is 
reported to interact with cell membranes by a 
fluorescent probe technique in intact cells,24 this is 70 
the first report that highlights membranes as a 
relevant site of drug activity other than DNA to be 
explored.  
Using cell and liposome models, it was observed that 
in both cases under aerobic conditions MUFA and 75 
PUFA residues partitioned between isomerisation and 
consumption processes, with the only difference that 
in living cells the final fatty acid composition is an 
effect of the phospholipid remodelling process 
associated to oxidative stress.25 80 
As chemical biology model for antitumoral strategies, 
liposomes highlighted the role of cell membranes, 
which are not spectators but important targets of the 
drug effect, with synergic roles for chemotherapeutic 
effects. Indeed, fatty acid recruitment and membrane 85 
formation attract a lot of interest in cancer, and in this 
context the loss of the natural cis geometry and the 
oxidation-induced lipid remodelling are worth of 
deeper studies in antitumoral strategies. Furthermore, 
the interaction between drugs and lipids can be 90 
suggestive of novel aspects of chemical reactivity for 
liposome carriers when circulating in vivo. 
 
Materials and methods 
The materials and general methods used in this work 95 
are described in Supplementary Information. 
 
Cell cultures, membrane phospholipid extraction 
and fatty acid analysis 
NTera-2 human testicular germ cancer cells were 100 
cultured in Dulbecco's Modified Eagle's Medium 
(DMEM) supplemented with 10% heat-inactivated 
BLM 
µM 
2-ME 
µM 
Trans 
18:1  
%a 
Trans 
18:2* 
%a 
PUFA 
consumpt.*
*%b 
10 10 2.3 ± 0.1 2 ± 0.2 14 ± 0.2 
0 10 0.9 ± 0.1 0.7 ± 0.1 0 
10 100 30.4 ± 0.9 41.2 ± 0.8 65.2 ± 0.7 
0 100 41.4 ± 1.0 46.6 ± 0.8 62.3 ± 0.9 
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fetal bovine serum (FBS), 100 units/mL of penicillin 
and 100 µg/mL of streptomycin in a 5% CO2 
atmosphere at 37 °C as described in the manual of the 
cell line bank. We used the half maximal inhibitory 
concentration (IC50) of bleomycin (400 µg/mL) for 24 5 
h incubations, determined in our previous studies and 
published.26 
 After incubation cells were detached using 
accutase, thoroughly washed with phosphate buffer, 
and pelleted by centrifugation at 14,000×g for 40 min 10 
at 4°C after adding water.  The pellet was 
resuspended in pure water and centrifuged for a 
second washing, then, dissolved in 2:1 
chloroform:methanol to extract phospholipids. The 
phospholipid extract was treated with 0.5M KOH in 15 
MeOH for 10 min at room temperature to convert 
fatty acid residues of phospholipids into their 
corresponding fatty acid methyl esters (FAME). After 
this transesterification step, FAMEs were extracted 
with n-hexane, and analyzed by gas chromatography 20 
(GC). Fatty acids (including cis and trans isomers) 
were identified by comparison with standard 
references used in previously reported studies.17-21 
Fatty acid compositions are calculated as relative 
percentages over the total fatty acid content and 25 
reported as means ± SD of a number of repetitions as 
indicated in Table 1. Statistical comparisons were 
conducted using the SPSS software, version 13.0 
(Chicago, IL), using t-test for group comparisons. 
Statistical significance was based on 95% confidence 30 
limits (p≤0.05). Comparison of the non-parametric 
data among the groups was performed using Mann-
Whitney U test. 
 
Liposome experiments  35 
Preparation of Large Unilamellar Vesicles by 
Extrusion Technique (LUVET) was carried out with 
1-palmitoyl-2-oleoyl phosphatidylcholine (POPC, 
Avanti Lipids) and with phospholipids from soybean 
lecithin (Sigma-Aldrich, Milan), as described 40 
elsewhere.17,18 The LUVET stock suspensions (70 
mM) were transferred in a vial and stored at 4 °C for 
a maximum of 2 weeks. From a stock solution 
prepared as LUVET suspension (70 mM 
phospholipid content) an aliquot (14.5 µL) was 45 
transferred in the reaction vial and tridistilled water 
was added to obtain a 1 mM phospholipid 
concentration (total reaction volume 1 mL). To the 
liposome suspension the bleomycin-iron complex (10 
µM each) and the thiol (in 10 µM or 100 µM 50 
concentration from stock solutions of 2-
mercaptoethanol, or other thiols such as cysteine, N-
acetyl-cysteine and glutathione, prepared in 
tridistilled water) were added consecutively. 4 mL 
vials containing 1 mL reaction volume were 55 
prepared, one was used as control and the 
experiments were run in triplicates incubating at 37 
°C, stopping the reaction after the desired time (24 h) 
for the work-up. Work-up was carried out as already 
reported in order to obtain the corresponding FAMEs 60 
examined by GC for the cis-trans isomer content.17,18 
To apply different oxygen concentrations, the 
appropriate mixtures nitrogen:oxygen containing 5%, 
10% and 20% oxygen were obtained by regulating 
the flux by a precision gas blending apparatus. The 65 
atmosphere was kept during the 24 hrs incubation 
period by attaching a balloon (wall thickness 12 mm) 
filled with the appropriate gas mixture to the reaction 
vial. Under similar conditions also blank experiments 
were carried out. Figure 2 and Table 2 report the 70 
results of all experiments. Palmitic acid as the main 
saturated fatty acid residue in the vesicle was used as 
an “internal” standard, in order to obtain quantitative 
information of the reaction yields. PUFA 
consumption was calculated by quantitating linoleic 75 
acid, based on the calibration of its GC peak area 
using palmitic acid as internal standard, at the 
beginning and after incubation (see Supplementary 
Information). 
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